Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 2;59(23):3106-3123.e12.
doi: 10.1016/j.devcel.2024.08.006. Epub 2024 Aug 30.

A conserved transcription factor regulatory program promotes tendon fate

Affiliations

A conserved transcription factor regulatory program promotes tendon fate

Xubo Niu et al. Dev Cell. .

Abstract

Tendons, which transmit force from muscles to bones, are highly prone to injury. Understanding the mechanisms driving tendon fate would impact efforts to improve tendon healing, yet this knowledge is limited. To find direct regulators of tendon progenitor emergence, we performed a zebrafish high-throughput chemical screen. We established forskolin as a tenogenic inducer across vertebrates, functioning through Creb1a, which is required and sufficient for tendon fate. Putative enhancers containing cyclic AMP (cAMP) response elements (CREs) in humans, mice, and fish drove specific expression in zebrafish cranial and fin tendons. Analysis of these genomic regions identified motifs for early B cell factor (Ebf/EBF) transcription factors. Mutation of CRE or Ebf/EBF motifs significantly disrupted enhancer activity and specificity in tendons. Zebrafish ebf1a/ebf3a mutants displayed defects in tendon formation. Notably, Creb1a/CREB1 and Ebf1a/Ebf3a/EBF1 overexpression facilitated tenogenic induction in zebrafish and human pluripotent stem cells. Together, our work identifies the functional conservation of two transcription factors in promoting tendon fate.

Keywords: Creb1a/CREB1; Ebf1a/Ebf3a/EBF1; cAMP; chemical screen; enhancer; forskolin/colforsin; scxa; tendon; zebrafish.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests L.I.Z. is a founder and stockholder of Fate Therapeutics, CAMP4 Therapeutics, Amagma Therapeutics, and Scholar Rock and is a consultant for Celularity.

References

    1. Brent AE, Schweitzer R, and Tabin CJ (2003). A somitic compartment of tendon progenitors. Cell 113, 235–248. 10.1016/S0092-8674(03)00268-X. - DOI - PubMed
    1. Chen JW, and Galloway JL (2014). The development of zebrafish tendon and ligament progenitors. Development 141, 2035–2045. 10.1242/dev.104067. - DOI - PMC - PubMed
    1. He P, Ruan D, Huang Z, Wang C, Xu Y, Cai H, Liu H, Fei Y, Heng BC, Chen W, et al. (2022). Comparison of Tendon Development Versus Tendon Healing and Regeneration. Preprint, 10.3389/fcell.2022.821667. - DOI - PMC - PubMed
    1. Cserjesi P, Brown D, Ligon KL, Lyons GE, Copeland NG, Gilbert DJ, Jenkins NA, and Olson EN (1995). Scleraxis: A basic helix-loop-helix protein that prefigures skeletal formation during mouse embryogenesis. Development. 10.1242/dev.121.4.1099. - DOI - PubMed
    1. Schweitzer R, Chyung JH, Murtaugh LC, Brent AE, Rosen V, Olson EN, Lassar A, and Tabin CJ (2001). Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments. Development 128, 3855–3866. 10.1242/dev.001933. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources